These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 32729185)
21. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells. Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020 [TBL] [Abstract][Full Text] [Related]
22. PIK3CA regulates development of diabetes retinopathy through the PI3K/Akt/mTOR pathway. Guan R; Kang Z; Li L; Yan X; Gao T PLoS One; 2024; 19(1):e0295813. PubMed ID: 38194422 [TBL] [Abstract][Full Text] [Related]
23. Dental pulp-derived stem cells inhibit osteoclast differentiation by secreting osteoprotegerin and deactivating AKT signalling in myeloid cells. Kanji S; Sarkar R; Pramanik A; Kshirsagar S; Greene CJ; Das H J Cell Mol Med; 2021 Mar; 25(5):2390-2403. PubMed ID: 33511706 [TBL] [Abstract][Full Text] [Related]
24. The efficacy and potential mechanism of cnidium lactone to inhibit osteoclast differentiation. Liang JY; Wu WL; Chen YX; Liu H Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3087-3093. PubMed ID: 31343277 [TBL] [Abstract][Full Text] [Related]
25. Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12. Kameda Y; Takahata M; Komatsu M; Mikuni S; Hatakeyama S; Shimizu T; Angata T; Kinjo M; Minami A; Iwasaki N J Bone Miner Res; 2013 Dec; 28(12):2463-75. PubMed ID: 23677868 [TBL] [Abstract][Full Text] [Related]
26. Actin-binding LIM protein 1 regulates receptor activator of NF-κB ligand-mediated osteoclast differentiation and motility. Jin SH; Kim H; Gu DR; Park KH; Lee YR; Choi Y; Lee SH BMB Rep; 2018 Jul; 51(7):356-361. PubMed ID: 29921413 [TBL] [Abstract][Full Text] [Related]
27. Lactic acid promotes metastatic niche formation in bone metastasis of colorectal cancer. Qian J; Gong ZC; Zhang YN; Wu HH; Zhao J; Wang LT; Ye LJ; Liu D; Wang W; Kang X; Sheng J; Xu W; Liu XL; Wu J; Zheng W Cell Commun Signal; 2021 Jan; 19(1):9. PubMed ID: 33478523 [TBL] [Abstract][Full Text] [Related]
28. [Mechanism of bulleyaconitine A in inhibiting bone destruction of rheumatoid arthritis via Src/PI3K/Akt signaling pathway]. Huang FY; Guo WY; Chen PP; Zhang XZ; Li ZH; Huang HL; Lin N; Su XH; Kong XY Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1438-1445. PubMed ID: 38621927 [TBL] [Abstract][Full Text] [Related]
29. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling. Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376 [TBL] [Abstract][Full Text] [Related]
30. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666 [TBL] [Abstract][Full Text] [Related]
31. Ultra-Small Lysozyme-Protected Gold Nanoclusters as Nanomedicines Inducing Osteogenic Differentiation. Li K; Zhuang P; Tao B; Li D; Xing X; Mei X Int J Nanomedicine; 2020; 15():4705-4716. PubMed ID: 32636626 [TBL] [Abstract][Full Text] [Related]
32. Depletion of the triggering receptor expressed on myeloid cells 2 inhibits progression of renal cell carcinoma via regulating related protein expression and PTEN-PI3K/Akt pathway. Zhang H; Sheng L; Tao J; Chen R; Li Y; Sun Z; Qian W Int J Oncol; 2016 Dec; 49(6):2498-2506. PubMed ID: 27779645 [TBL] [Abstract][Full Text] [Related]
33. A pterostilbene derivative suppresses osteoclastogenesis by regulating RANKL-mediated NFκB and MAPK signaling in RAW264.7 cells. Nikhil K; Sharan S; Roy P Pharmacol Rep; 2015 Dec; 67(6):1264-72. PubMed ID: 26481551 [TBL] [Abstract][Full Text] [Related]
34. Hydrogen sulphide promotes osteoclastogenesis by inhibiting autophagy through the PI3K/AKT/mTOR pathway. Ma J; Du D; Liu J; Guo L; Li Y; Chen A; Ye T J Drug Target; 2020 Feb; 28(2):176-185. PubMed ID: 31134826 [TBL] [Abstract][Full Text] [Related]
35. The Coumarin Derivative 5'-Hydroxy Auraptene Suppresses Osteoclast Differentiation via Inhibiting MAPK and c-Fos/NFATc1 Pathways. Abdallah BM; Ali EM; Elsawy H; Badr GM; Abdel-Moneim AM; Alzahrani AM Biomed Res Int; 2019; 2019():9395146. PubMed ID: 31976330 [TBL] [Abstract][Full Text] [Related]
36. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1. Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277 [TBL] [Abstract][Full Text] [Related]
37. Study on the treatment of postmenopausal osteoporosis with quercetin in Liuwei Dihuang Pill based on network pharmacology. Zhu F; Li W; Wang L; Dai B; Liu Z; Wu H; Deng T J Orthop Surg Res; 2023 Jan; 18(1):21. PubMed ID: 36624462 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of TREM-1 ameliorates Lipopolysaccharide-induced depressive-like behaviors by alleviating neuroinflammation in the PFC via PI3K/Akt signaling pathway. Fu A; Qiao F; Feng H; Luo Q Behav Brain Res; 2023 Jul; 449():114464. PubMed ID: 37142164 [TBL] [Abstract][Full Text] [Related]
39. Macrolactin F inhibits RANKL-mediated osteoclastogenesis by suppressing Akt, MAPK and NFATc1 pathways and promotes osteoblastogenesis through a BMP-2/smad/Akt/Runx2 signaling pathway. Li L; Sapkota M; Gao M; Choi H; Soh Y Eur J Pharmacol; 2017 Nov; 815():202-209. PubMed ID: 28919027 [TBL] [Abstract][Full Text] [Related]
40. Berberine inhibits IL-21/IL-21R mediated inflammatory proliferation of fibroblast-like synoviocytes through the attenuation of PI3K/Akt signaling pathway and ameliorates IL-21 mediated osteoclastogenesis. Dinesh P; Rasool M Cytokine; 2018 Jun; 106():54-66. PubMed ID: 29549724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]